In terms of another survival kinase p-ERK1/2 levels, AF group decreased p-ERK1/2 levels compared with control group, whereas both 72 h fasting groups showed an increase in p-ERK1/2 compared with AF or control (p < 0.01) (Figure 3B). The gene discussed is MAPK3; the disease is atrial fibrillation.